Dr. Laura Johnetta Blakely, MD

Dr. Blakely practices at Tennessee Oncology in Franklin, Tennessee.

Dr. Blakely's NPI, 1265464499, was assigned on July 7, 2006. Dr. Blakely graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1998. Dr. Blakely holds Tennessee license 38475.

Dr. Blakely's primary practice is Tennessee Oncology, at 4488 Carothers Pkwy, Franklin, TN 37067 in Williamson County. The practice phone is (615) 329-0570.

Dr. Blakely's primary practice is Tennessee Oncology in Franklin, Tennessee. Dr. Blakely is also affiliated with Ascension Saint Thomas Hospital West. The medical group on file is Tennessee Oncology. Dmand AI also links Dr. Blakely to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blakely practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Blakely's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Blakely is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Blakely's licenses on file in 3 states: Tennessee, Arkansas and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Blakely treats.

CMS data shows 39,316 Medicare services from Dr. Blakely across 60 procedure codes in 2024, for 436 Medicare patients. Medicare paid $334,930 for them. Every service was in an office.

CMS counts 436 Medicare patients who saw Dr. Blakely in 2024. The largest group is 65 to 74, with 207 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blakely's median patient age at 68, with 69% women.

In 2024, Dr. Blakely wrote 957 Medicare Part D claims for 237 patients. 80% of them were for generic drugs. CMS names the drug for 764 of them, across 19 drugs with 11 or more claims each, at $1,519,296 in total drug cost. In 2023, CMS named 871 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Blakely for performance year 2024, reported as part of a group. Dr. Blakely accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blakely as offering telehealth.

Dmand AI links 19 papers to Dr. Blakely, published from 2013 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Neoplasm Metastasis. Dr. Blakely has published most often in Clin Breast Cancer. Dr. Blakely's most frequent co-authors are Lee S. Schwartzberg, MD, Aman U. Buzdar, MD and Aurelio B. Castrellon, MD.

Dmand AI links Dr. Blakely to 1 clinical trial. Conditions studied include Lymphoma, T-Cell, Peripheral and Lymphoma, T-Cell.

CMS Open Payments shows 231 general payments to Dr. Blakely from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,739. It also lists 5 research payments totaling $2,743 from 2021 to 2025.

Dmand AI lists 2 awards for Dr. Blakely, most recently NCQA PPC in 2012.

Dr. Blakely graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1998. Dr. Blakely is a member of ACP.

Dr. Blakely is in network with 21 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.